Pseudomonas immunotherapy: a historical overview
- PMID: 15040935
- DOI: 10.1016/j.vaccine.2003.11.028
Pseudomonas immunotherapy: a historical overview
Abstract
The historic development of vaccines to be used as immunotherapy for Pseudomonas aeruginosa infections, in various patient populations, is reviewed. Commentary is offered concerning the relevance of each approach in light of our current understanding of the pathological process of these infections.
Similar articles
-
Development of immunotherapy for infections due to Pseudomonas aeruginosa.J Infect Dis. 1974 Nov;130 Suppl(0):S149-51. doi: 10.1093/infdis/130.supplement.s149. J Infect Dis. 1974. PMID: 4138585 No abstract available.
-
[Development of immunological preparations and their use for preventing and treating pyocyanic infection in burn patients].Probl Gematol Pereliv Krovi. 1981 Jan;26(1):29-33. Probl Gematol Pereliv Krovi. 1981. PMID: 6784114 Clinical Trial. Russian. No abstract available.
-
Vaccines and immunotherapy against Pseudomonas aeruginosa.Vaccine. 2008 Feb 20;26(8):1011-24. doi: 10.1016/j.vaccine.2007.12.007. Epub 2007 Dec 26. Vaccine. 2008. PMID: 18242792 Review.
-
[Immunotherapy with monovalent Pseudomonas aeruginosa vaccine in chronic bronchopulmonary infections].Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1983 Jul-Sep;32(3):261-72. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1983. PMID: 6318298 Romanian. No abstract available.
-
Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.Expert Rev Vaccines. 2005 Oct;4(5):645-56. doi: 10.1586/14760584.4.5.645. Expert Rev Vaccines. 2005. PMID: 16221066 Review.
Cited by
-
The study of formulated Zoush ointment against wound infection and gene expression of virulence factors Pseudomonas aeruginosa.BMC Complement Altern Med. 2018 Jun 15;18(1):185. doi: 10.1186/s12906-018-2251-4. BMC Complement Altern Med. 2018. PMID: 29903005 Free PMC article.
-
X-ray Irradiated Vaccine Confers protection against Pneumonia caused by Pseudomonas aeruginosa.Sci Rep. 2016 Feb 16;6:18823. doi: 10.1038/srep18823. Sci Rep. 2016. PMID: 26879055 Free PMC article.
-
Exploiting immunopotential PAPI-1 encoded type IVb major pilin targeting Pseudomonas aeruginosa.Heliyon. 2024 Aug 24;10(17):e36859. doi: 10.1016/j.heliyon.2024.e36859. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39281519 Free PMC article.
-
Immunization with Bivalent Flagellin Protects Mice against Fatal Pseudomonas aeruginosa Pneumonia.J Immunol Res. 2017;2017:5689709. doi: 10.1155/2017/5689709. Epub 2017 Oct 19. J Immunol Res. 2017. PMID: 29201922 Free PMC article.
-
RGD capsid modification enhances mucosal protective immunity of a non-human primate adenovirus vector expressing Pseudomonas aeruginosa OprF.Clin Exp Immunol. 2013 Aug;173(2):230-41. doi: 10.1111/cei.12101. Clin Exp Immunol. 2013. PMID: 23607394 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources